174 related articles for article (PubMed ID: 23542011)
1. D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.
McDougle RM; Hultquist JF; Stabell AC; Sawyer SL; Harris RS
Virology; 2013 Jun; 441(1):31-9. PubMed ID: 23542011
[TBL] [Abstract][Full Text] [Related]
2. Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species.
Auerbach AA; Becker JT; Moraes SN; Moghadasi SA; Duda JM; Salamango DJ; Harris RS
mSphere; 2022 Dec; 7(6):e0045122. PubMed ID: 36374108
[TBL] [Abstract][Full Text] [Related]
3. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.
Molan AM; Hanson HM; Chweya CM; Anderson BD; Starrett GJ; Richards CM; Harris RS
Virology; 2017 Nov; 511():74-81. PubMed ID: 28841445
[TBL] [Abstract][Full Text] [Related]
5. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
6. Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution.
Schmitt K; Guo K; Algaier M; Ruiz A; Cheng F; Qiu J; Wissing S; Santiago ML; Stephens EB
Virology; 2011 Oct; 419(1):24-42. PubMed ID: 21868050
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.
Stenglein MD; Harris RS
J Biol Chem; 2006 Jun; 281(25):16837-16841. PubMed ID: 16648136
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
9. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
10. The APOBEC3B cytidine deaminase is an adenovirus restriction factor.
Lejeune N; Mathieu S; Decloux A; Poulain F; Blockx Z; Raymond KA; Willemart K; Vartanian JP; Suspène R; Gillet NA
PLoS Pathog; 2023 Feb; 19(2):e1011156. PubMed ID: 36745676
[TBL] [Abstract][Full Text] [Related]
11. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
Verhalen B; Starrett GJ; Harris RS; Jiang M
J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
Chaipan C; Smith JL; Hu WS; Pathak VK
J Virol; 2013 Jan; 87(1):444-53. PubMed ID: 23097438
[TBL] [Abstract][Full Text] [Related]
13. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
Hultquist JF; Lengyel JA; Refsland EW; LaRue RS; Lackey L; Brown WL; Harris RS
J Virol; 2011 Nov; 85(21):11220-34. PubMed ID: 21835787
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.
Siriwardena SU; Guruge TA; Bhagwat AS
J Mol Biol; 2015 Sep; 427(19):3042-55. PubMed ID: 26281709
[TBL] [Abstract][Full Text] [Related]
15. Divergence in Dimerization and Activity of Primate APOBEC3C.
Gaba A; Hix MA; Suhail S; Flath B; Boysan B; Williams DR; Pelletier T; Emerman M; Morcos F; Cisneros GA; Chelico L
J Mol Biol; 2021 Dec; 433(24):167306. PubMed ID: 34666043
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
Ooms M; Krikoni A; Kress AK; Simon V; Münk C
J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription.
Chen Y; Hu J; Cai X; Huang Y; Zhou X; Tu Z; Hu J; Tavis JE; Tang N; Huang A; Hu Y
Antiviral Res; 2018 Jan; 149():16-25. PubMed ID: 29129707
[TBL] [Abstract][Full Text] [Related]
18. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
Adolph MB; Love RP; Feng Y; Chelico L
Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
[TBL] [Abstract][Full Text] [Related]
19. A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
Zhou T; Han Y; Dang Y; Wang X; Zheng YH
Retrovirology; 2009 Apr; 6():31. PubMed ID: 19344514
[TBL] [Abstract][Full Text] [Related]
20. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B; Senger T; Manning G; Landau NR
J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
